Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$326,917
-$25,935 QoQ
Shares Held
2,086
-9.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,080
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
This page
|
2,086 | $326,917 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,917 | 2,086 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $352,852 | 2,310 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $311,724 | 2,261 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $250,837 | 1,956 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $321,038 | 2,653 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $312,923 | 2,807 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $299,324 | 3,076 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $353,800 | 3,076 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $333,964 | 3,137 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $296,863 | 3,069 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $309,876 | 3,069 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $345,100 | 3,388 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $330,075 | 3,271 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $307,464 | 3,342 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $303,185 | 3,342 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $262,081 | 3,448 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $292,050 | 3,455 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $317,304 | 3,616 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $325,650 | 3,723 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $525,763 | 6,429 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $332,387 | 3,643 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $308,838 | 3,613 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $343,347 | 3,636 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $298,967 | 3,438 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $300,274 | 3,438 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $269,611 | 3,270 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||